| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |